Digital Rectal Examination
"Digital Rectal Examination" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A physical examination in which the qualified health care worker inserts a lubricated, gloved finger of one hand into the RECTUM and may use the other hand to press on the lower ABDOMEN or pelvic area to palpate for abnormalities in the lower rectum, and nearby organs or tissues. The method is commonly used to check the lower rectum, the PROSTATE gland in men, and the UTERUS and OVARIES in women.
Descriptor ID |
D051517
|
MeSH Number(s) |
E01.370.600.600.500
|
Concept/Terms |
Digital Rectal Examination- Digital Rectal Examination
- Digital Rectal Examinations
- Examination, Digital Rectal
- Examinations, Digital Rectal
- Rectal Examination, Digital
- Rectal Examinations, Digital
- Rectal Palpation
- Palpation, Rectal
- Palpations, Rectal
- Rectal Palpations
|
Below are MeSH descriptors whose meaning is more general than "Digital Rectal Examination".
Below are MeSH descriptors whose meaning is more specific than "Digital Rectal Examination".
This graph shows the total number of publications written about "Digital Rectal Examination" by people in this website by year, and whether "Digital Rectal Examination" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2006 | 2 | 0 | 2 |
2007 | 0 | 3 | 3 |
2008 | 0 | 2 | 2 |
2009 | 1 | 0 | 1 |
2012 | 1 | 1 | 2 |
2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Digital Rectal Examination" by people in Profiles.
-
Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial. BJU Int. 2019 05; 123(5):854-860.
-
Prostate cancer specific survival in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial. Cancer Epidemiol. 2012 Dec; 36(6):e401-6.
-
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012 Jan 18; 104(2):125-32.
-
Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009 Mar 26; 360(13):1310-9.
-
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial. BJU Int. 2008 Dec; 102(11):1524-30.
-
Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Causes Control. 2008 Dec; 19(10):1267-76.
-
Patient selection determines the prostate cancer yield of dynamic contrast-enhanced magnetic resonance imaging-guided transrectal biopsies in a closed 3-Tesla scanner. BJU Int. 2008 Jan; 101(2):181-5.
-
Magnetic resonance imaging-directed transrectal ultrasonography-guided biopsies in patients at risk of prostate cancer. BJU Int. 2007 May; 99(5):1041-6.
-
Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial. BJU Int. 2007 Apr; 99(4):775-9.
-
Clinical utilization of digital rectal examination and fecal occult blood testing upon hospital admission. J Clin Gastroenterol. 2006 Nov-Dec; 40(10):913-8.